Immediate Impact

3 from Science/Nature 52 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
7 intermediate papers

Works of Lindsey Stevens being referenced

RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033).
2017
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014

Author Peers

Author Last Decade Papers Cites
Lindsey Stevens 276 41 203 93 14 314
Natalia Colocci 224 31 168 126 15 303
Ronald Boonstra 216 14 187 135 10 298
H Schefer 155 54 137 85 14 323
Emanuela Anna Pesce 250 29 164 64 11 279
Viola Pöschel 227 30 180 72 8 284
Giorgia Annechini 143 22 129 71 24 280
Vittoria Tarantino 255 112 147 29 12 340
Anne Kirsti Blystad 227 40 181 73 14 321
Krishnaswamy Madhavan 182 31 162 32 13 265
José-Luis Pico 193 43 164 59 9 350

All Works

Loading papers...

Rankless by CCL
2026